Viridiantherapeutics

Ethyreal Bio

This company develops monoclonal antibodies to treat Graves' disease and thyroid eye disease for patients with these autoimmune conditions.

Yarrow Bioscience

This biotechnology company develops monoclonal antibody therapies for patients with autoimmune thyroid conditions, including Graves' disease and thyroid eye disease.

Tourmaline Bio

This biotechnology firm develops antibody therapeutics for patients with immune and inflammatory conditions, including atherosclerotic cardiovascular disease and thyroid eye disease.

Vor Bio

This biotechnology company develops therapies for patients living with serious autoantibody-driven autoimmune diseases, such as myasthenia gravis and Sjögren's disease.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

Ollin Bio

This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.

Dren bio

This biopharmaceutical company develops antibody therapeutics to treat patients with cancer, autoimmune conditions, and neurological diseases.